Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.278.70 CHF
Change Today -0.90 / -0.32%
Volume 1.1M
As of 11:43 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Severin Schwan Ph.D.

Chief Executive Officer and Director, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 48 board members in 6 different organizations across 13 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Severin Schwan, Ph.D. has been Chief Executive Officer of Roche Holding AG since March 2008. Dr. Schwan has been Group Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2008. He served as the Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006. He served as Chief Executive Officer of Diagnostics Division at Roche Holding AG since January 2006. He served as Trainee of Corporate Finance at Roche Basel from 1993 to ...

Read Full Background

Corporate Headquarters*

Basel, Basel-Stadt 4070


Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Chairman of the Board
Chief Executive Officer and Director
Director and Member of Risk Committee
Director and Member of Risk Committee
Director and Member of Risk Committee


Unknown/Other Education
University of Oxford
Unknown/Other Education 1991
Universität Innsbruck
LLB 1991
Universität Innsbruck
Unknown/Other Education
University of York
Doctorate 1993
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

Total Annual CompensationSFr.5,340,136

Stock Options*

Restricted Stock AwardsSFr.6,056,252
All Other CompensationSFr.553,246
Total Value of OptionsSFr.22,155,938
Total Number of Options289,794

Total Compensation*

Total Annual Cash CompensationSFr.5,893,382
Total Short Term CompensationSFr.5,340,136
Other Long Term CompensationSFr.6,609,498
Total Calculated CompensationSFr.11,949,634
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.278.70 CHF -0.90


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at